C4 Therapeutics
Ka Ying Sharon H. is a Senior Scientist at C4 Therapeutics, Inc. with previous experience at Biogen, Harvard Medical School, Harvard University, Rockefeller University, and the University of Wisconsin-Madison. In their various roles, Ka Ying Sharon has conducted research in areas such as AAV capsid engineering, ubiquitin-proteasome system, RNA-binding proteins, and zinc finger proteins. Ka Ying Sharon holds a Ph.D. in Biological and Biomedical Sciences from Harvard University and a Bachelor of Science in Genetics from the University of Wisconsin-Madison.
C4 Therapeutics
6 followers
C4 Therapeutics (C4T) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.